Penn Medicine Abramson Cancer Center

 

Penn Medicine Abramson Cancer Center
C

The Making of the Tisagenlecleucel CAR T

By Penn Medicine Abramson Cancer Center FEATURING Carl June
By Penn Medicine Abramson Cancer Center FEATURING Carl June
213 views
March 30, 2018
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
Immunotherapy
16:30
Penn Medicine Abramson Cancer Center

New Immunotherapy Discoveries for NSCLC: What Are Available Approach…

Feat. C. Aggarwal
18:16
Penn Medicine Abramson Cancer Center

The Promise of Proton and Stereotactic Radiation Therapy for Early a…

Feat. S. Feigenberg
22:23
Penn Medicine Abramson Cancer Center

IO for Pancreatic Cancer: Microenvironment and Resistance Mechanisms…

Feat. G. Beatty
09:58
Penn Medicine Abramson Cancer Center

How do you make T-cells better?

Feat. C. June
08:13
Penn Medicine Abramson Cancer Center

Challenges and Opportunities with CAR T-cells

Feat. C. June
05:15
Penn Medicine Abramson Cancer Center

Combinatorial Cancer Immunotherapies

Feat. C. June
10:07
Penn Medicine Abramson Cancer Center

Using CAR T in Solid Tumors?

Feat. C. June
08:18
Penn Medicine Abramson Cancer Center

The Making of the Tisagenlecleucel CAR T

Feat. C. June
31:49
Penn Medicine Abramson Cancer Center

CD 19 CAR T-cells in Leukemia

Feat. S. Grupp